Stem Cell Clinic

Bacardis Make Gift to Significantly Advance Mayo Clinic's Regenerative Medicine Research

By Uncategorized

Released: 29-Jul-2014 8:00 AM EDT Source Newsroom: Mayo Clinic Contact Information

Available for logged-in reporters only

Newswise JACKSONVILLE, Fla. Imagine a future in which a new lung is grown for a patient in need, using the patients own cellular material, or a day when an injection of replacement cells will enable a patient to self-heal damage in the brain, nerves or other tissues.

MULTIMEDIA ALERT: For audio and video of Dr. Keller and Jorge Bacardi talking about the gift and regenerative medicine, visit the Mayo Clinic News Network.

Regenerative medicine is no longer science fiction, and a substantial gift from Jorge and Leslie Bacardi of the Bahamas will significantly accelerate the research of Mayo Clinics Center for Regenerative Medicine on the Florida campus.

Jorge Bacardi, whose family has manufactured rum and other spirits for 150 years, suffered since childhood with primary ciliary dyskinesia, a debilitating lung disease that nearly ended his life. A double lung transplant at Mayos Florida campus in 2008 enabled him to take his first full breath of air at age 64.

Regenerative medicine is an extraordinary step in the evolution of mankind, says Jorge Bacardi. It is for Leslie and I a great honor to be able to join Mayo Clinic in the development of such an advancement in the medical field."

Regenerative medicine is addressing the root causes of disease and disability by developing ways to rejuvenate the body using its natural self-healing processes; replace damaged cells with healthy ones derived from the patient (avoiding immune system rejection); and regenerate function by applying specific cells or cell products.

Mayos regenerative medicine researchers are targeting conditions throughout the body, including heart disease, stroke, Alzheimers disease and traumatic injuries that affect combat veterans. Some studies are in the earliest stages. Others are in clinical trials with patients.

Researchers now can differentiate stem cells into skin, brain, lung and many other types of cells. For example, a patient's own skin cells may be collected, reprogrammed in a laboratory to give them certain characteristics, and then delivered back to the patient to treat diseases at various places within the body.

Read the original:
Bacardis Make Gift to Significantly Advance Mayo Clinic's Regenerative Medicine Research

Brisbane mother dies in Russia

By Stem Cell Treatment

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Read more:
Brisbane mother dies in Russia

Queensland mum dies in Russia

By Stem Cell Treatment

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Go here to see the original:
Queensland mum dies in Russia

Qld mum dies in Russia

By Stem Cell Treatment

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Read the original post:
Qld mum dies in Russia

Stem cell treatment warnings

By Stem Cell Doctors

Video will begin in 5 seconds.

While stem cells have many applications in treating bone tumors and early leukaemia and lymphoma cases Dr Tony Bartone says patients undergoing unproven treatments are taking "life into a Tatts Lotto" situation.

Authorities are warning of the risks of unproven stem cell treatments available in Australia and overseas after the death of an Australian woman in Russia.

Brisbane mother-of-two Kellie van Meurs travelled to Moscow for treatment for a rare neurological disorder called Stiff Person Syndrome but died from a heart attack while undergoing the controversial treatment on July 19.

Her death - and the continued marketing of stem cell tourism by groups including Adult Stem Cell Foundation - prompted warnings that manyof the therapies on offer are untested and not acceptedby mainstream science.

Stem Cells Australia's head of education, ethics, law and community awareness Megan Munsie said a proliferation of private clinics combined with a growing consumer base was a potentially dangerous mix.

Advertisement

''This sad case illustrates that some people are prepared to take the risk,'' she said. ''But people should balance their high hopes with the acknowledgement that there is a risk.''

She also cautioned that treatment decisions should be based more on the advice of medical professionals than the experiences outlined in social media, which was flush with success stories and often failed to reflect reality.

In December the country's main medical research funding body, the National Health and Medical Research Council, released a guide for patients and doctors highlighting the risks associated with unproven stem cell treatments in Australia and overseas.

Read more from the original source:
Stem cell treatment warnings

Stem cell treatment warnings after Australian woman dies in Russia

By Stem Cell Doctors

Video will begin in 5 seconds.

While stem cells have many applications in treating bone tumors and early leukaemia and lymphoma cases Dr Tony Bartone says patients undergoing unproven treatments are taking "life into a Tatts Lotto" situation.

Authorities are warning of the risks of unproven stem cell treatments available in Australia and overseas after the death of an Australian woman in Russia.

Brisbane mother-of-two Kellie van Meurs travelled to Moscow for treatment for a rare neurological disorder called Stiff Person Syndrome but died from a heart attack while undergoing the controversial treatment on July 19.

Her death - and the continued marketing of stem cell tourism by groups including Adult Stem Cell Foundation - prompted warnings that manyof the therapies on offer are untested and not acceptedby mainstream science.

Stem Cells Australia's head of education, ethics, law and community awareness Megan Munsie said a proliferation of private clinics combined with a growing consumer base was a potentially dangerous mix.

Advertisement

''This sad case illustrates that some people are prepared to take the risk,'' she said. ''But people should balance their high hopes with the acknowledgement that there is a risk.''

She also cautioned that treatment decisions should be based more on the advice of medical professionals than the experiences outlined in social media, which was flush with success stories and often failed to reflect reality.

In December the country's main medical research funding body, the National Health and Medical Research Council, released a guide for patients and doctors highlighting the risks associated with unproven stem cell treatments in Australia and overseas.

Link:
Stem cell treatment warnings after Australian woman dies in Russia

'Sad case' reveals stem cell risk

By Stem Cell Doctors

Video will begin in 5 seconds.

While stem cells have many applications in treating bone tumors and early leukaemia and lymphoma cases Dr Tony Bartone says patients undergoing unproven treatments are taking "life into a Tatts Lotto" situation.

Authorities are warning of the risks of unproven stem cell treatments available in Australia and overseas after the death of an Australian woman in Russia.

Brisbane mother-of-two Kellie van Meurs travelled to Moscow for treatment for a rare neurological disorder called Stiff Person Syndrome but died from a heart attack while undergoing the controversial treatment on July 19.

Her death - and the continued marketing of stem cell tourism by groups including Adult Stem Cell Foundation - prompted warnings that manyof the therapies on offer are untested and not acceptedby mainstream science.

Stem Cells Australia's head of education, ethics, law and community awareness Megan Munsie said a proliferation of private clinics combined with a growing consumer base was a potentially dangerous mix.

Advertisement

''This sad case illustrates that some people are prepared to take the risk,'' she said. ''But people should balance their high hopes with the acknowledgement that there is a risk.''

She also cautioned that treatment decisions should be based more on the advice of medical professionals than the experiences outlined in social media, which was flush with success stories and often failed to reflect reality.

In December the country's main medical research funding body, the National Health and Medical Research Council, released a guide for patients and doctors highlighting the risks associated with unproven stem cell treatments in Australia and overseas.

Excerpt from:
'Sad case' reveals stem cell risk

Mum dies during stem cell therapy

By Stem Cell Doctors

Kellie van Meurs, pictured with her husband Mark, died while undergoing stem cell treatment in Russia. Photo: Facebook

Supporters of a Brisbane mother-of-two who died while undergoing a controversial stem cell treatment in Russia say it did not cause her death, nor have others been discouraged from seeking it.

Kellie van Meurs suffered from a rare neurological disorder called stiff person syndrome, which causes progressive rigidity of the body and chronic pain.

She travelled to Moscow in late June to undergo an autologous haematopoietic stem cell transplant (HSCT) under the care of Dr Denis Fedorenko from the National Pirogov Medical Surgical Centre.

Kellie van Meurs, pictured with family and supporters, died while undergoing stem cell treatment in Russia. Photo: Facebook

The transplant more commonly used for multiple sclerosis patients involves rebooting a patients immune system with their own stem cells after high-dose chemotherapy.

Advertisement

Ms van Meurs was Dr Fedorenkos first SPS patient, and her husband Mark said she died of a heart attack on July 19.

I do know that Rosemary [Ms van Meurs' aunt and carer in Moscow] felt she received the best possible care, especially from Dr Fedorenko, he said.

Given her level of constant pain and overlapping auto-neuronal problems I still don't think we had a better option.

Read the original post:
Mum dies during stem cell therapy

Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019

By Stem Cell Medicine

(PRWEB) July 28, 2014

According to a new market research report published by Transparency Market Research "Regenerative Medicine (Bone and Joint) Market (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global regenerative medicine (bone and joint) market was valued at USD 2.6 billion in 2012 and is estimated to reach a market worth of USD 6.5 billion in 2019 growing at a CAGR of 12.8% from 2013 to 2019.

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint) market. However, ethical issues pertaining to stem cell therapy and fear of disease transmission due to allogeneic bone implantation are considered as market hindering factors during the study period. Companies operating in this market focus on investing in emerging economies of Asia-Pacific such as India, China, Japan and South Korea. These economies represent huge potential for various bone and joint reconstructive products due to rising healthcare expenditure and presence of large patient pool suffering from arthritis disorder (rheumatoid arthritis).

Title: Regenerative Medicine (Bone and Joint) Market Published: 1 July 2014 Pages: 85 Price: US$ 4,795.00 (Single User) For further inquiries, click here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419.

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. However, high cost associated with biomaterials is a factor that would restrict the global market demand to some extent during the study period.

In addition, based on applications the global market for regenerative medicine (bone and joint) is segmented as bone graft substitute, osteoarticular diseases, allergenic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. However, post implantation rejection associated with bone graft substitute is considered as a crucial factor that would restrict the global market demand of bone graft substitute.

Browse the Press Release of Regenerative Medicine Market @ http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm

On the basis of geography, the regenerative medicine (bone and joint) market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America accounted for the largest market share for regenerative medicine (bone and joint) globally in 2012 owing to increase in orthopaedic re-constructive surgeries and introduction of technologically advanced medical devices and products. According to the American Academy of Orthopedic Surgeons (AAOS), prevalence of Lumbar Spinal Stenosis (LSS) is increasing with rise in elderly population and is estimated that approximately 2.4 million Americans would be affected by LSS by 2021. It has also stated that in 1990 approximately 129,000 Total Knee Arthroplasty (TKA) surgeries were performed in the U.S. Europe accounted for the second largest share in the global regenerative medicine (bone and joint) market in 2012.

Large geriatric population base is one of the important factors driving the growth of regenerative medicine bone and joint application market in this region. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019, due to large pool of potential reconstructive surgery patients and strong support from federal government. Additionally, companies are expecting large revenue with sufficient market penetration from Asia-Pacific region and thereby focusing on increasing investments in this region. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region.

Major market players having presence in the global regenerative medicine (bone and joint) market include DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler), Orthofix, Inc. (Trinity Evolution) and NuVasive, Inc. (Osteocel Plus).

Continued here:
Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

→←